Khanjan Gandhi
Overview
Explore the profile of Khanjan Gandhi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
242
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaur J, Chandrashekar D, Varga Z, Sobottka B, Janssen E, Gandhi K, et al.
Genes (Basel)
. 2023 Sep;
14(9).
PMID: 37761830
Purpose: Triple-negative breast cancer (TNBC) is a molecularly complex and heterogeneous breast cancer subtype with distinct biological features and clinical behavior. Although TNBC is associated with an increased risk of...
2.
Shah S, Carlson C, Lai K, Zhong Z, Marsico G, Lee K, et al.
Nat Mater
. 2023 Mar;
22(4):511-523.
PMID: 36928381
Activated B-cell-like diffuse large B-cell lymphomas (ABC-DLBCLs) are characterized by constitutive activation of nuclear factor κB driven by the B-cell receptor (BCR) and Toll-like receptor (TLR) pathways. However, BCR-pathway-targeted therapies...
3.
Zhu J, Wang Y, Li J, Das P, Zhang H, Passang T, et al.
Blood
. 2022 Apr;
140(12):1431-1447.
PMID: 35443019
Vasoactive intestinal polypeptide (VIP), an anti-inflammatory neuropeptide with pleiotropic cardiovascular effects, induces differentiation of hematopoietic stem cells into regulatory dendritic cells that limit graft-versus-host disease (GVHD) in allogeneic hematopoietic stem...
4.
Khadilkar S, Nallamilli B, Bhutada A, Hegde M, Gandhi K, Faldu H, et al.
J Neurol Sci
. 2017 Mar;
375:239-240.
PMID: 28320138
No abstract available.
5.
Kowalski J, Dwivedi B, Newman S, Switchenko J, Pauly R, Gutman D, et al.
Nucleic Acids Res
. 2016 Jan;
44(7):e69.
PMID: 26826710
The identification of genes with specific patterns of change (e.g. down-regulated and methylated) as phenotype drivers or samples with similar profiles for a given gene set as drivers of clinical...
6.
Yang R, Chen L, Newman S, Gandhi K, Doho G, Moreno C, et al.
Cancer Inform
. 2014 Oct;
13(Suppl 2):49-53.
PMID: 25288879
We present a pipeline to perform integrative analysis of mate-pair (MP) and paired-end (PE) genomic DNA sequencing data. Our pipeline detects structural variations (SVs) by taking aligned sequencing read pairs...
7.
Brodie S, Lombardo C, Li G, Kowalski J, Gandhi K, You S, et al.
PLoS One
. 2014 Sep;
9(9):e107124.
PMID: 25222296
Purpose: Aberrant promoter DNA methylation can serve as a predictive biomarker for improved clinical responses to certain chemotherapeutics. One of the major advantages of methylation biomarkers is the ease of...
8.
Colbert L, Petrova A, Fisher S, Pantazides B, Madden M, Hardy C, et al.
Cancer Res
. 2014 Mar;
74(10):2677-87.
PMID: 24626090
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with poor outcomes with current therapies. Gemcitabine is the primary adjuvant drug used clinically, but its effectiveness is limited. In this study,...
9.
Brodie S, Li G, El-Kommos A, Kang H, Ramalingam S, Behera M, et al.
Cancer Prev Res (Phila)
. 2014 Jan;
7(3):351-61.
PMID: 24441677
DNA methylation is an early event in bronchial carcinogenesis and increased DNA methyltransferase (DNMT)1 protein expression is a crucial step in the oncogenic transformation of epithelia. Here, we investigate the...
10.
Colbert L, Fisher S, Hardy C, Hall W, Saka B, Shelton J, et al.
Cancer
. 2013 May;
119(17):3148-55.
PMID: 23720157
Background: Mixed lineage kinase domain-like protein (MLKL) is a necrosome component mediating programmed necrosis that may be an important determinant of cancer cell death. The goal of the current study...